How much does tirzepatide cost without insurance per month?

The Real Numbers for Tirzepatide in 2026

Tirzepatide pricing has become substantially more accessible than it was at launch, largely due to Lilly's direct-to-patient program. Current paths:

Brand Zepbound (Obesity Indication)

• Pharmacy list price: ~$1,060/month at retail
• LillyDirect self-pay: $349 (2.5 mg), $449 (5 mg), $499 (7.5 mg and higher) per month in vial form
• Pre-filled pen (standard): ~$1,060 list, similar to retail pharmacy

LillyDirect's vial-based self-pay program has significantly changed the economics of brand tirzepatide for uninsured patients. The catch: you reconstitute and self-inject from vials rather than using pre-filled pens, which requires minor additional supplies and learning the technique.

Brand Mounjaro (Type 2 Diabetes Indication)

• List price: ~$1,060/month
• Cash price at pharmacy: close to list
• Manufacturer savings cards apply primarily to insured patients with commercial coverage

Compounded Tirzepatide

Compounded tirzepatide through telehealth peptide clinics has remained available despite the evolving compounding regulatory landscape. April 2026 pricing:

• Titration doses (2.5–5 mg weekly): $200–$300/month
• Maintenance doses (10–15 mg weekly): $350–$500/month
• All-inclusive of telehealth provider consultation
• Quality varies by clinic and pharmacy — not all compounded tirzepatide is equal

Dose-Dependent Pricing

Tirzepatide pricing scales with dose. Doses studied: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg weekly. Most patients titrate from 2.5 mg up to 10 mg or 15 mg. When comparing clinic pricing, ask:

• What's the price at the dose I expect to be on long-term?
• Does the price change as I escalate doses?
• Are dose changes included or do they trigger new consultation fees?

Insurance Coverage in 2026

Coverage for tirzepatide has expanded substantially:

• Most commercial insurance covers Zepbound for obesity with BMI ≥30, or BMI ≥27 with a weight-related comorbidity
• Mounjaro is broadly covered for type 2 diabetes
• Medicare Part D coverage for Zepbound expanded in 2025, still varies by plan
• Medicaid coverage varies significantly by state
• Employer self-funded plans increasingly cover GLP-1s/dual agonists, often with prior authorization and sometimes step therapy

Before paying cash, verify coverage. A $30 copay for brand Zepbound is hard to beat.

Pharmacy Comparison for Zepbound

• CVS, Walgreens, Walmart: list price ~$1,060
• Costco: often modest $30–$80 below list
• Mark Cuban Cost Plus Drugs: Zepbound not currently stocked as of April 2026
• GoodRx cash card: limited discount on Zepbound
• LillyDirect: meaningfully cheaper vial-based self-pay program

What Drives Compounded Price

• Active pharmaceutical ingredient (API) cost
• Compounding pharmacy overhead (sterile facility, testing, personnel)
• Telehealth clinic margin
• Provider consultation and follow-up
• Shipping (often cold chain)

Total Monthly Cost Paths

• Cheapest legitimate compounded (titration dose): $200/month
• Compounded at maintenance: $350–$500/month
• LillyDirect vial at therapeutic dose: $449–$499/month
• Brand full cash: $1,000–$1,100/month
• Brand with insurance coverage: $25–$100/month copay

See the tirzepatide guide. Related: tirzepatide dosage chart, tirzepatide vs retatrutide.